TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN

NCT00539630 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Squamous Cell

Interventions

DRUG: Docetaxel

Sponsor

Sanofi